Close

Burning Rock Biotech (BNR) Announces Exclusive in-Licensing of Risk Stratification Test for Early Stage Lung-Cancer Patients from Oncocyte (OCX) in China

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. LRCX
4. IBM
5. SPY
6. BA
7. HCP
8. SNAP
9. TMUS
10. MSFT


Go back to Burning Rock Biotech (BNR) Announces Exclusive in-Licensing of Risk Stratification Test for Early Stage Lung-Cancer Patients from Oncocyte (OCX) in China
(NASDAQ: BNR) Delayed: 0.85 +0.03 (3.66%)
Previous Close $0.82    52 Week High $ 
Open $0.85    52 Week Low $ 
Day High $0.88    P/E N/A 
Day Low $0.79    EPS $ 
Volume 42,687       

(NASDAQ: OCX) Delayed: 2.44 -0.02 (0.81%)
Previous Close $2.46    52 Week High $10.24 
Open $2.45    52 Week Low $2.45 
Day High $2.49    P/E N/A 
Day Low $2.35    EPS $-0.46 
Volume 26,258